Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (3) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Diecke, Sebastian Dr. (6) Falcke, Martin Prof. Dr. (1) Friedrich, Corinna (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinz, Michael Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kolesnichenko, Marina Dr. (1) Kühn, Ralf Dr. (1) Lacadie, Scott Allen Dr. (1) Müthel, Stefanie (1) Ofenbauer, Andreas Dr. (1) Popp, Oliver Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (2) Suarez Artiles, Lorena Dr. (1) Uyar, Bora Dr. (3) Vucicevic, Dubravka (1) Willnow, Thomas Prof. Dr. (1) Wolf, Susanne Dr. (1) Zauber, Henrik Dr. (2) (-) Hirsekorn, Antje (1) (-) Kirchner, Marieluise Dr. (4) (-) Mertins, Philipp Dr. (10) (-) Tursun, Baris Dr. (1) 2006 (1) 2008 (1) 2011 (1) 2012 (3) 2013 (6) 2014 (4) 2015 (6) 2016 (3) 2017 (5) (-) 2018 (14) 2019 (10) 2020 (13) 2021 (12) 2022 (18) 2023 (17) 2024 (6) Bioinformatics and Omics Data Science (3) Cellular Neurosciences (1) Computational Regulatory Genomics (3) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (1) Genetics and Genomics of Cardiovascular Diseases (1) Genome Engineering & Disease Models (1) Genomics (2) Integrative Vascular Biology (1) Magnetic Resonance (1) Mathematical Cell Physiology (1) Molecular Cardiovascular Research (3) (-) Pluripotent Stem Cells (2) Proteome Dynamics (3) (-) Proteomics (12) Psychoneuroimmunology (1) RNA Biology and Posttranscriptional Regulation (3) Transgenics (1) Translational Bioinformatics (1) Translational Cardiology and Functional Genomics (1) 14 Results: Active Filter: Hirsekorn, AntjeKirchner, Marieluise Dr.Mertins, Philipp Dr.Tursun, Baris Dr.Pluripotent Stem CellsProteomics2018 Sort: Result score Newest to oldest Oldest to newest February 15, 2018 / Cancer Res Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells P.Y. Chen M.D. Muzumdar K.J. Dorans R.A. Robbins A. Bhutkar A.M. Del Rosario P. Mertins J. Qiao C. Schaefer F.B. Gertler S.A. Carr T. Jacks March 01, 2018 / Nat Genet CLCN2 chloride channel mutations in familial hyperaldosteronism type II U.I. Scholl G. Stölting J. Schewe A. Thiel H. Tan C. Nelson-Williams A.A. Vichot S.C. Jin E. Loring V. Untiet T. Yoo J. Choi S. Xu A. Wu M. Kirchner P. Mertins L.C. Rump A.M. Onder C. Gamble D. McKenney R.W. Lash D.P. Jones G. Chune P. Gagliardi M. Choi R. Gordon M. Stowasser C. Fahlke R.P. Lifton February 22, 2018 / Cell Pervasive, coordinated protein-level changes driven by transcript isoform switching during meiosis Z. Cheng G.M. Otto E.N. Powers A. Keskin P. Mertins S.A. Carr M. Jovanovic G.A. Brar May 01, 2018 / Cancer Res Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers F. Mundt S. Rajput S. Li K.V. Ruggles A.D. Mooradian P. Mertins M.A. Gillette K. Krug Z. Guo J. Hoog P. Erdmann-Gilmore T. Primeau S. Huang D.P. Edwards X. Wang X. Wang E. Kawaler D.R. Mani K.R. Clauser F. Gao J. Luo S.R. Davies G.L. Johnson K.L. Huang C.J. Yoon L. Ding D. Fenyö M.J. Ellis R.R. Townsend J.M. Held S.A. Carr C.X. Ma February 28, 2018 / Nat Methods Picky: a simple online PRM and SRM method designer for targeted proteomics H. Zauber M. Kirchner M. Selbach July 01, 2018 / Nat Med Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition G.S. Wong J. Zhou J.B. Liu Z. Wu X. Xu T. Li D. Xu S.E. Schumacher J. Puschhof J. McFarland C. Zou A. Dulak L. Henderson P. Xu E. O'Day R. Rendak W.L. Liao F. Cecchi T. Hembrough S. Schwartz C. Szeto A.K. Rustgi K.K. Wong J.A. Diehl K. Jensen F. Graziano A. Ruzzo S. Fereshetian P. Mertins S.A. Carr R. Beroukhim K. Nakamura E. Oki M. Watanabe H. Baba Y. Imamura D. Catenacci A.J. Bass September 13, 2018 / Blood PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells J.D. Kahn P.G. Miller A.J. Silver R.S. Sellar S. Bhatt C. Gibson M. McConkey D. Adams B. Mar P. Mertins S. Fereshetian K. Krug H. Zhu A. Letai S.A. Carr J. Doench S. Jaiswal B.L. Ebert July 01, 2018 / Nat Protoc Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry P. Mertins L.C. Tang K. Krug D.J. Clark M.A. Gritsenko L. Chen K.R. Clauser T.R. Clauss P. Shah M.A. Gillette V.A. Petyuk S.N. Thomas D.R. Mani F. Mundt R.J. Moore Y. Hu R. Zhao M. Schnaubelt H. Keshishian M.E. Monroe Z. Zhang N.D. Udeshi D. Mani S.R. Davies R.R. Townsend D.W. Chan R.D. Smith H. Zhang T. Liu S.A. Carr September 10, 2018 / Dev Cell FACT sets a barrier for cell fate reprogramming in Caenorhabditis elegans and human cells E. Kolundzic A. Ofenbauer S.I. Bulut B. Uyar G. Baytek A. Sommermeier S. Seelk M. He A. Hirsekorn D. Vucicevic A. Akalin S. Diecke S.A. Lacadie B. Tursun November 01, 2018 / Mol Biol Cell On the relation between filament density, force generation and protrusion rate in mesenchymal cell motility S. Dolati F. Kage J. Mueller M. Müsken M. Kirchner G. Dittmar M. Sixt K. Rottner M. Falcke Pagination Current page 1 Page 2 Next page Next › Last page Last »
February 15, 2018 / Cancer Res Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells P.Y. Chen M.D. Muzumdar K.J. Dorans R.A. Robbins A. Bhutkar A.M. Del Rosario P. Mertins J. Qiao C. Schaefer F.B. Gertler S.A. Carr T. Jacks
March 01, 2018 / Nat Genet CLCN2 chloride channel mutations in familial hyperaldosteronism type II U.I. Scholl G. Stölting J. Schewe A. Thiel H. Tan C. Nelson-Williams A.A. Vichot S.C. Jin E. Loring V. Untiet T. Yoo J. Choi S. Xu A. Wu M. Kirchner P. Mertins L.C. Rump A.M. Onder C. Gamble D. McKenney R.W. Lash D.P. Jones G. Chune P. Gagliardi M. Choi R. Gordon M. Stowasser C. Fahlke R.P. Lifton
February 22, 2018 / Cell Pervasive, coordinated protein-level changes driven by transcript isoform switching during meiosis Z. Cheng G.M. Otto E.N. Powers A. Keskin P. Mertins S.A. Carr M. Jovanovic G.A. Brar
May 01, 2018 / Cancer Res Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers F. Mundt S. Rajput S. Li K.V. Ruggles A.D. Mooradian P. Mertins M.A. Gillette K. Krug Z. Guo J. Hoog P. Erdmann-Gilmore T. Primeau S. Huang D.P. Edwards X. Wang X. Wang E. Kawaler D.R. Mani K.R. Clauser F. Gao J. Luo S.R. Davies G.L. Johnson K.L. Huang C.J. Yoon L. Ding D. Fenyö M.J. Ellis R.R. Townsend J.M. Held S.A. Carr C.X. Ma
February 28, 2018 / Nat Methods Picky: a simple online PRM and SRM method designer for targeted proteomics H. Zauber M. Kirchner M. Selbach
July 01, 2018 / Nat Med Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition G.S. Wong J. Zhou J.B. Liu Z. Wu X. Xu T. Li D. Xu S.E. Schumacher J. Puschhof J. McFarland C. Zou A. Dulak L. Henderson P. Xu E. O'Day R. Rendak W.L. Liao F. Cecchi T. Hembrough S. Schwartz C. Szeto A.K. Rustgi K.K. Wong J.A. Diehl K. Jensen F. Graziano A. Ruzzo S. Fereshetian P. Mertins S.A. Carr R. Beroukhim K. Nakamura E. Oki M. Watanabe H. Baba Y. Imamura D. Catenacci A.J. Bass
September 13, 2018 / Blood PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells J.D. Kahn P.G. Miller A.J. Silver R.S. Sellar S. Bhatt C. Gibson M. McConkey D. Adams B. Mar P. Mertins S. Fereshetian K. Krug H. Zhu A. Letai S.A. Carr J. Doench S. Jaiswal B.L. Ebert
July 01, 2018 / Nat Protoc Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry P. Mertins L.C. Tang K. Krug D.J. Clark M.A. Gritsenko L. Chen K.R. Clauser T.R. Clauss P. Shah M.A. Gillette V.A. Petyuk S.N. Thomas D.R. Mani F. Mundt R.J. Moore Y. Hu R. Zhao M. Schnaubelt H. Keshishian M.E. Monroe Z. Zhang N.D. Udeshi D. Mani S.R. Davies R.R. Townsend D.W. Chan R.D. Smith H. Zhang T. Liu S.A. Carr
September 10, 2018 / Dev Cell FACT sets a barrier for cell fate reprogramming in Caenorhabditis elegans and human cells E. Kolundzic A. Ofenbauer S.I. Bulut B. Uyar G. Baytek A. Sommermeier S. Seelk M. He A. Hirsekorn D. Vucicevic A. Akalin S. Diecke S.A. Lacadie B. Tursun
November 01, 2018 / Mol Biol Cell On the relation between filament density, force generation and protrusion rate in mesenchymal cell motility S. Dolati F. Kage J. Mueller M. Müsken M. Kirchner G. Dittmar M. Sixt K. Rottner M. Falcke